Concepedia

Romeo Maciuca

RM

19

Publications

3.6K

Citations

15

H-Index

2012

Active since

Affiliations

Denali Therapeutics (United States)(Current)

Allergy Associates Research Center

University of British Columbia

University of Rochester

Oklahoma Medical Research Foundation

Romeo Maciuca is an author at Denali Therapeutics (United States) specializing in medicine, allergy, and immunology.

ORCID

Top concepts

Publications per year

2012–2023

19

Publications

19

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study

Brad H. Rovin, Richard Furie, Kevin Latinis et al. · Arthritis & Rheumatism · 2012 · 1.4K citations

Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies

Nicola A. Hanania, Michael Noonan, Jonathan Corren et al. · Thorax · 2015 · 374 citations · Full text

Efficacy and Safety of Ocrelizumab in Active Proliferative Lupus Nephritis: Results From a Randomized, Double‐Blind, Phase III Study

Eduardo Mysler, Alberto Spindler, Renato Guzmán et al. · Arthritis & Rheumatism · 2013 · 345 citations · Full text

A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE)

Kenneth Kalunian, Joan T. Merrill, Romeo Maciuca et al. · Annals of the Rheumatic Diseases · 2015 · 335 citations

Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson’s disease

Danna Jennings, Sarah Huntwork‐Rodriguez, Anastasia G. Henry et al. · Science Translational Medicine · 2022 · 230 citations

Rows per page

1–5 of 19